Literature DB >> 16904669

TRIM11 binds to and destabilizes a key component of the activator-mediated cofactor complex (ARC105) through the ubiquitin-proteasome system.

Hideaki Ishikawa1, Hiroyuki Tachikawa, Yutaka Miura, Nobuhiro Takahashi.   

Abstract

TRIM11 is a member of the tripartite-motif-containing protein family and is known to destabilize humanin, an inhibitor of Alzheimer-like neuronal insults. In this study, we demonstrate that TRIM11 interacts with activator-recruited cofactor 105-kDa component (ARC105) that mediates chromatin-directed transcription activation and is a key regulatory factor for transforming growth factor beta (TGFbeta) signaling. Co-expression of TRIM11 increased ARC105 degradation but a proteasome inhibitor suppressed this. Co-expression of TRIM11 and ARC105 also increased ubiquitination of ARC105. In addition, TRIM11 suppressed ARC105-mediated transcriptional activation induced with TGFbeta in a reporter assay. These results suggest that TRIM11, with the ubiquitin-proteasome pathway, regulates ARC105 function in TGFbeta signaling.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16904669     DOI: 10.1016/j.febslet.2006.07.066

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  22 in total

1.  Trim11 modulates the function of neurogenic transcription factor Pax6 through ubiquitin-proteosome system.

Authors:  Tran Cong Tuoc; Anastassia Stoykova
Journal:  Genes Dev       Date:  2008-07-15       Impact factor: 11.361

2.  Analysis of the human endogenous coregulator complexome.

Authors:  Anna Malovannaya; Rainer B Lanz; Sung Yun Jung; Yaroslava Bulynko; Nguyen T Le; Doug W Chan; Chen Ding; Yi Shi; Nur Yucer; Giedre Krenciute; Beom-Jun Kim; Chunshu Li; Rui Chen; Wei Li; Yi Wang; Bert W O'Malley; Jun Qin
Journal:  Cell       Date:  2011-05-27       Impact factor: 41.582

3.  Contribution of E3-ubiquitin ligase activity to HIV-1 restriction by TRIM5alpha(rh): structure of the RING domain of TRIM5alpha.

Authors:  Maritza Lienlaf; Fumiaki Hayashi; Francesca Di Nunzio; Naoya Tochio; Takanori Kigawa; Shigeyuki Yokoyama; Felipe Diaz-Griffero
Journal:  J Virol       Date:  2011-07-06       Impact factor: 5.103

4.  Modulation of PLAGL2 transactivation by positive cofactor 2 (PC2), a component of the ARC/Mediator complex.

Authors:  Sara J Wezensky; Tracey S Hanks; Michelle J Wilkison; Mary Cloud Ammons; Daniel W Siemsen; Katherine A Gauss
Journal:  Gene       Date:  2009-12-16       Impact factor: 3.688

5.  Tyr99 phosphorylation determines the regulatory milieu of tumor suppressor p73.

Authors:  Y K Satija; S Das
Journal:  Oncogene       Date:  2015-04-20       Impact factor: 9.867

6.  Rhesus monkey TRIM5α has distinct HIV-1 restriction activity among different mammalian cell lines.

Authors:  Jian Gong; Xi-Hui Shen; Hui Qiu; Chao Chen; Rong-Ge Yang
Journal:  Curr Microbiol       Date:  2011-09-24       Impact factor: 2.188

7.  Trim11 increases expression of dopamine beta-hydroxylase gene by interacting with Phox2b.

Authors:  Seok Jong Hong; Han Chae; Thomas Lardaro; Sunghoi Hong; Kwang-Soo Kim
Journal:  Biochem Biophys Res Commun       Date:  2008-02-12       Impact factor: 3.575

Review 8.  TRIM family proteins and their emerging roles in innate immunity.

Authors:  Keiko Ozato; Dong-Mi Shin; Tsung-Hsien Chang; Herbert C Morse
Journal:  Nat Rev Immunol       Date:  2008-11       Impact factor: 53.106

9.  Modulation of retroviral restriction and proteasome inhibitor-resistant turnover by changes in the TRIM5alpha B-box 2 domain.

Authors:  Felipe Diaz-Griffero; Alak Kar; Michel Perron; Shi-Hua Xiang; Hassan Javanbakht; Xing Li; Joseph Sodroski
Journal:  J Virol       Date:  2007-07-11       Impact factor: 5.103

10.  TRIM11 is overexpressed in high-grade gliomas and promotes proliferation, invasion, migration and glial tumor growth.

Authors:  K Di; M E Linskey; D A Bota
Journal:  Oncogene       Date:  2012-11-26       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.